Shares of Amgen have rallied at the start of 2025 despite the broader stock market sell-off. Reliable dividend income from high-quality companies is a great option for investors seeking to ride out stock market turbulence. Biotech giant Amgen (NASDAQ: AMGN) exemplifies this strategy with its 3.3% dividend yield, supported by steady growth and rock-solid fundamentals.
Font: Llegir més